1. Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S. Obesity and women's health: an evidence-based review. J Am Board Fam Med. 2011;24(1):75-85. [
DOI:10.3122/jabfm.2011.01.100076] [
PMID]
2. Davis ME, Blake C, Perrotta C, Cunningham C, O'Donoghue G. Impact of training modes on fitness and body composition in women with obesity: A systematic review and meta‐analysis. Obesity. 2022;30(2):300-19. [
DOI:10.1002/oby.23305] [
PMID]
3. Mohammadi F, Ghalavand A, Delaramnasab M. Effect of circuit resistance training and L-Carnitine supplementation on body composition and liver function in men with non-Alcoholic fatty liver disease. Jundishapur J Chronic Dis Care. 2019;8(4):e90213. https://repository.brieflands.com/items/29e4f47b-1dc2-487a-b49c-0116603249fb/full [
DOI:10.5812/jjcdc.90213]
4. Johnston EK, Abbott RD. Adipose tissue paracrine-, Autocrine-, and matrix-dependent signaling during the development and progression of obesity. Cells. 2023;12(3):407. [
DOI:10.3390/cells12030407] [
PMID] [
PMCID]
5. Ghalavand A, Mohammadpour M, RahmaniGhobadi M, Motamedi P, Hovsepian A. Changes in the serum levels of metabotropic biomarkers (asprosin and BDNF) in adapting to intermittent aerobic training. Ilam. 202:31. http://sjimu.medilam.ac.ir/article-1-7675-en.html
6. Gruber T, Pan C, Contreras RE, Wiedemann T, Morgan DA, Skowronski AA, et al. Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension. Cell Metab. 2021;33(6):1155-70. e10. [
DOI:10.1016/j.cmet.2021.04.007] [
PMID] [
PMCID]
7. Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and obesity: role and clinical implication. Front Endocrinol. 2021;12:585887. [
DOI:10.1161/CIRCRESAHA.107.156596] [
PMID]
8. Pretz D, Le Foll C, Rizwan MZ, Lutz TA, Tups A. Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity. FASEB. 2021;35(2):e21216.
https://doi.org/10.1096/fj.202001147R [
DOI:10.1096/fj.202001147r] [
PMID]
9. Farrag M, Ait Eldjoudi D, González-Rodríguez M, Cordero-Barreal A, Ruiz-Fernández C, Capuozzo M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol. 2023;13:1101091. [
DOI:10.3389/fendo.2022.1101091] [
PMID] [
PMCID]
10. Mirr M, Braszak-Cymerman A, Ludziejewska A, Kręgielska-Narożna M, Bogdański P, Bryl W et al. Serum Asprosin Correlates with Indirect Insulin Resis Indices Biomed. 2023;11(6):1568. [
DOI:10.3390/biomedicines11061568] [
PMID] [
PMCID]
11. London E, Nesterova M, Sinaii N, Szarek E, Chanturiya T, Mastroyannis SA, et al. Differentially regulated protein kinase A (PKA) activity in adipose tissue and liver is associated with resistance to diet-induced obesity and glucose intolerance in mice that lack PKA regulatory subunit type IIα. Endocrinology. 2014;155(9):3397-408. [
DOI:10.1210/en.2014-1122] [
PMID] [
PMCID]
12. Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, et al. Asprosin is a centrally acting orexigenic hormone. Nature Med. 2017;23(12):1444-53.
https://doi.org/10.1038/nm.4432 [
DOI:10.1038%2Fnm.4432] [
PMID] [
PMCID]
13. Ozcan S, Ulker N, Bulmus O, Yardimci A, Ozcan M, Canpolat S. The modulatory effects of irisin on asprosin, leptin, glucose levels and lipid profile in healthy and obese male and female rats. Arch Physiol Biochem. 2022;128(3):724-31. [
DOI:10.1080/13813455.2020.1722706] [
PMID]
14. Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: A review. Diabetes Obes Metabol. 2023;25(1):18-35. [
DOI:10.1111/dom.14863] [
PMID] [
PMCID]
15. Oppert J-M, Ciangura C, Bellicha A. Physical activity and exercise for weight loss and maintenance in people living with obesity. Rev Endocr Metab Disord. 2023:1-13. [
DOI:10.1007/s11154-023-09805-5] [
PMID]
16. O'Donoghue G, Blake C, Cunningham C, Lennon O, Perrotta C. What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta‐analysis. Obes Rev. 2021;22(2):e13137. [
DOI:10.1111/obr.13137] [
PMID] [
PMCID]
17. Baker A, Sirois-Leclerc H, Tulloch H. The impact of long-term physical activity interventions for overweight/obese postmenopausal women on adiposity indicators, physical capacity, and mental health outcomes: a systematic review. J Obes. 2016;2016. [
DOI:10.1155/2016/6169890] [
PMID] [
PMCID]
18. London E, Stratakis CA. The regulation of PKA signaling in obesity and in the maintenance of metabolic health. Pharmacol Ther. 2022;237:108113. [
DOI:10.1016/j.pharmthera.2022.108113] [
PMID]
19. Meister BM, Hong S-G, Shin J, Rath M, Sayoc J, Park J-Y. Healthy versus unhealthy adipose tissue expansion: the role of exercise. J Obes Metab Syndrome. 2022;31(1):37. [
DOI:10.7570/jomes21096] [
PMID] [
PMCID]
20. Pourvaghar MJ, Noori Mofrad SR, Khalafi M. The effect of high-intensity interval training on circulating leptin levels in individuals with and without chronic diseases: a systematic review and meta-analysis. J Sport Biosci. 2023;15(1):47-63. http://dx.doi.org/10.22059/JSB.2023.354347.1570
21. Makiel K, Suder A, Targosz A, Maciejczyk M, Kozioł-Kozakowska A, Haim A. Impact of two types of exercise interventions on leptin and omentin concentrations and indicators of lipid and carbohydrate metabolism in males with metabolic syndrome. J Clin Med. 2023;12(8):2822. [
DOI:10.3390/jcm12082822] [
PMID] [
PMCID]
22. Ouerghi N, Fradj MKB, Duclos M, Bouassida A, Feki M, Weiss K, et al. Effects of high-intensity interval training on selected adipokines and cardiometabolic risk markers in normal-weight and overweight/obese young males-A pre-post test trial. Biology. 2022;11(6):853.
https://doi.org/10.3390/biology11060853 [
DOI:10.3390%2Fbiology11060853] [
PMID] [
PMCID]
23. Aktaş H, Uzun Y, Kutlu O, Pençe H, Özçelik F, Çil E, et al. The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome. Archives of physiology and biochemistry. 2022;128(1):37-42. [
DOI:10.1080/13813455.2019.1662450] [
PMID]
24. Ceylan Hİ, Öztürk ME, Öztürk D, Silva AF, Albayrak M, Saygın Ö, et al. Acute effect of moderate and high-intensity interval exercises on asprosin and BDNF levels in inactive normal weight and obese individuals. Sci Report. 2023;13(1):7040. https://www.nature.com/articles/s41598-023-34278-6 [
DOI:10.1038/s41598-023-34278-6] [
PMID] [
PMCID]
25. Ryan BJ, Schleh MW, Ahn C, Ludzki AC, Gillen JB, Varshney P, et al. Moderate-intensity exercise and high-intensity interval training affect insulin sensitivity similarly in obese adults. J Clin Endocrinol Metab. 2020;105(8):e2941-e59. [
DOI:10.1210/clinem/dgaa345] [
PMID] [
PMCID]
26. Ceylan Hİ, Saygın Ö, Özel Türkçü Ü. Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men. Chronobiol Int. 2020;37(8):1252-68. [
DOI:10.1080/07420528.2020.1792482] [
PMID]
27. Engin B, Willis SA, Malaikah S, Sargeant JA, Yates T, Gray LJ, et al. The effect of exercise training on adipose tissue insulin sensitivity: A systematic review and meta‐analysis. Obes Rev. 2022;23(7):e13445. [
DOI:10.1111/obr.13445] [
PMID]
28. Liu L, Liu Y, Huang M, Zhang M, Zhu C, Chen X, et al. The effects of asprosin on exercise-intervention in metabolic diseases. Front physiol. 2022;13:907358.
https://doi.org/10.3389/fphys.2022.907358 [
DOI:10.3389%2Ffphys.2022.907358] [
PMID] [
PMCID]
29. Khalafi M, Symonds M. Impact of exercise training plus caloric restriction on cardiometabolic health in menopausal women who are overweight or obese: A meta-analysis. Sci Sport. 2023;38(2):116-26. [
DOI:10.1016/j.scispo.2022.01.007]
30. Kraemer RR, Chu H, Castracane VD. Leptin and exercise. Exp Biol Med. 2002;227(9):701-8. [
DOI:10.1177/153537020222700903] [
PMID]